Fig. 5From: Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinomaPlots of the relapse-free (A) and overall (B) survival probabilities predicted by the multivariable Cox’s regression fitted model as a function of the combined geminin/MCM7 labeling indices (LI) from LSCC of both patient groups. The ratios of geminin/MCM7 LI according to HER1/HER3 phenotypes of LSCC of bioradiotherapy with cetuximab (C) and upfront surgery with or without postoperative radio/chemo-radiotherapy (D) treated patient groupsBack to article page